Please assess the completion status of the following clinical trial:

Trial Title: Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Infertile lean women with PCOS as defined by the Rotterdam criteria.~* CC resistance (defined as failure of ovulation after receiving 150 mg/day of CC for 5 consecutive days per cycle, for at least 3 consecutive cycles).~Exclusion Criteria:~* Age \< 20 or \> 35 years.~* Presence of any infertility factor other than anovulatory PCOS.~* Previous history of ovarian surgery or surgical removal of one ovary.~* Previous exposure to cytotoxic drugs or pelvic irradiation.~* Oral hypoglycemic or hormonal therapy either currently or in the preceding 3 months.~* Metabolic or hormonal abnormalities.

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 35 Years
- Healthy Volunteers: f

Study Arms:
- Clomiphene citrate-HCG group (Type: ACTIVE_COMPARATOR): Women will receive clomiphene citrate and human chorionic gonadotropin (HCG)
- Clomiphene citrate group (Type: ACTIVE_COMPARATOR): Women will receive clomiphene citrate alone

Based on this trial design, predict the completion outcome and termination type (if applicable).